Trials / Conditions / Hypopharyngeal Cancer

Hypopharyngeal Cancer

20 registered clinical trials studyying Hypopharyngeal Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions NCT07532538	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	—
Recruiting	Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal NCT06039631	Fudan University	Phase 2
Recruiting	The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer NCT05894070	Insel Gruppe AG, University Hospital Bern	—
Recruiting	Immune Biomarker Study for Head and Neck Cancer NCT05375266	University of Erlangen-Nürnberg Medical School	—
Unknown	Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypoph NCT05860335	Chinese PLA General Hospital	Phase 2
Unknown	Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carci NCT05420597	Fudan University	Phase 2
Unknown	Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer NCT04539600	Sun Yat-sen University	Phase 2
Unknown	Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial NCT04502641	Sun Yat-sen University	Phase 3
Completed	Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients NCT03934294	China Medical University Hospital	N/A
Completed	Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NCT02113878	Dana-Farber Cancer Institute	Phase 1
Unknown	New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Ca NCT03558035	Chinese Academy of Medical Sciences	Phase 2
Recruiting	Integrated Cancer Repository for Cancer Research NCT02012699	University of Nebraska	—
Unknown	Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx NCT01516996	The Second People's Hospital of Sichuan	Phase 2
Completed	A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuxima NCT01435252	University of Zurich	Phase 2
Completed	Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) NCT01312350	Samsung Medical Center	Phase 2
Withdrawn	Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract NCT01175499	University of California, San Francisco	N/A
Completed	Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery NCT00473564	University of Alabama at Birmingham	N/A
Unknown	The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma NCT00302562	National Taiwan University Hospital	—
Unknown	The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal NCT00174096	National Taiwan University Hospital	—
Unknown	The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis NCT00173381	National Taiwan University Hospital	—